TL;DR
This paper introduces ACID, an open-source MATLAB toolbox that extends the SPM software for comprehensive processing and modeling of diffusion MRI (dMRI) data from the brain, spinal cord, and ex vivo specimens. ACID addresses key challenges in dMRI analysis, including artifact correction, advanced diffusion modeling, and biophysical parameter estimation, making it a valuable tool for neuroscience research.
What Problem Does This Paper Address?
Diffusion MRI (dMRI) is a powerful technique for imaging tissue microstructure, with growing applications beyond the brain to the spinal cord and ex vivo samples. However, analyzing dMRI data is complex due to artifacts (motion, eddy currents, susceptibility) and the need for sophisticated models to interpret the signal. Existing toolboxes often focus on brain data, lack comprehensive artifact correction, or don't integrate advanced biophysical models. This paper addresses the need for a unified, user-friendly, and extensible toolbox that can handle the unique challenges of dMRI analysis across different tissue types and experimental conditions, while also adhering to data standardization principles like BIDS.
Methods
ACID is built upon the Statistical Parametric Mapping (SPM) framework, leveraging its robust image processing and statistical analysis capabilities. Key methodological contributions include:
- Artifact Correction: State-of-the-art algorithms for eddy current and motion correction (ECMOCO), adaptive denoising (msPOAS), Rician bias correction (RBC), and susceptibility artifact correction (HySCO). Notably, ECMOCO offers slice-wise registration for improved spinal cord alignment.
- Diffusion Modeling: Implementation of Diffusion Tensor Imaging (DTI) and Diffusion Kurtosis Imaging (DKI) with various fitting algorithms (OLS, WLS, robust fitting, NLLS).
- Biophysical Modeling: Inclusion of models like WMTI-Watson and NODDI-DTI to estimate microstructural properties such as axonal water fraction and orientation dispersion.
- BIDS Compliance: Adherence to the Brain Imaging Data Structure (BIDS) standard for organized data output, facilitating sharing and compatibility with other tools.
- Modularity and Extensibility: A modular design allows for seamless integration of external tools and customization of analysis pipelines.
Datasets
The paper describes the use of three example datasets for demonstrating ACID's capabilities:
- An in vivo brain dMRI dataset.
- An in vivo spinal cord dMRI dataset.
- An ex vivo temporal lobe specimen dMRI dataset.
Details on the scan parameters for these datasets are provided in Table 4.
Key Insights and Ideas
- Spinal Cord dMRI Challenges: Analyzing spinal cord dMRI is significantly more challenging than brain dMRI due to lower SNR, complex motion (respiration, pulsation), and different artifact profiles, requiring specialized correction strategies like slice-wise registration.
- Biophysical Models for Microstructure: Biophysical models offer a more direct link between dMRI signal and tissue microstructure, providing parameters like axonal water fraction and orientation dispersion, which are crucial for understanding tissue health and disease.
- BIDS Standardization: Adopting BIDS is essential for reproducible research, data sharing, and interoperability with the growing ecosystem of neuroimaging tools.
- SPM Integration: Leveraging SPM's established framework provides ACID users with access to a wide range of powerful tools for segmentation, spatial normalization, and statistical analysis, creating a unified analysis environment.
Key Results
- ACID provides a comprehensive pipeline from raw DICOM data to group-level statistics.
- The toolbox successfully processes dMRI data from brain, spinal cord, and ex vivo specimens.
- Example pipelines demonstrate the effectiveness of artifact correction and model fitting for these different data types.
- Parallel computing is implemented to accelerate processing, with computation times provided for selected modules.
- ACID has been used in various clinical and neuroscience research studies, including those on multiple sclerosis, Parkinson's disease, gliomas, and spinal cord injury.
Limitations and Future Work
- Parameter Optimization: Performance can be highly dependent on parameter settings, necessitating systematic exploration for optimal results on specific datasets.
- Quantitative Comparison: A dedicated future study is warranted for a thorough quantitative comparison of ACID with other toolboxes.
- Ongoing Development: The authors acknowledge ongoing developments and plan to integrate more advanced biophysical models and estimators (e.g., Rician maximum likelihood estimator).
- Clinical Use: ACID is intended for academic research purposes and is not approved for clinical diagnosis.
Summary updated